CRISPR

$78.38

+$1.15 (+1.48%) Today
-$0.23 (-0.29%) As of 12:00 AM UTC after-hours
1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. 

CEO
Samarth Kulkarni
CEOSamarth Kulkarni
Employees
473
Employees473
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2013
Founded2013
Employees
473
Employees473

CRSP Key Statistics

Market cap
6.09B
Market cap6.09B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.31M
Average volume1.31M
High today
$80.10
High today$80.10
Low today
$76.39
Low today$76.39
Open price
$77.54
Open price$77.54
Volume
902.75K
Volume902.75K
52 Week high
$135.70
52 Week high$135.70
52 Week low
$42.51
52 Week low$42.51

CRSP News

Benzinga 5d
Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US - Yahoo Finance

Barclays says that CRISPR Therapeutics AG's (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical prog...

Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US - Yahoo Finance

Analyst ratings

63%

of 27 ratings
Buy
63%
Hold
33.3%
Sell
3.7%

CRSP Earnings

-$2.40
$1.55
$5.49
$9.44
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
-$2.23 per share
Estimated-$2.23 per share
Actual
-$2.40 per share
Actual-$2.40 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.